ABBV Filing
4Filing Date: May 12, 2026
AbbVie Inc. (ABBV) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001239126-26-000002open_in_new
Total Value$0
Trades2
Insiders1
Transaction Details
FREYMAN THOMAS C
Director·Direct
Grant · Acquire
Common Stock, $0.01 par value
Shares+1.12K
Price$0.00
Total Value$0
Shares Owned After127.87K
Transaction DateMay 8, 2026
Footnotes ▸
These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
FREYMAN THOMAS C
Director·Indirect · By spouse in trust
Common Stock, $0.01 par value
Shares0
Price-
Total Value$0
Shares Owned After4.00K
Footnotes ▸
The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
Post-Transaction Holdings
FREYMAN THOMAS C
| Security | Shares | Change |
|---|---|---|
| Common Stock, $0.01 par value | 131.87K | +1.12K (0.86%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-08
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: AbbVie Inc. (ABBV)
CIK: 0001551152
--- Reporting Owner ---
Name: FREYMAN THOMAS C
CIK: 0001239126
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock, $0.01 par value
Date: 2026-05-08 | Code: A (Grant or award)
Shares: +1,118 | Price: $0.00
Shares Owned After: 127,869 | Ownership: D (Direct)
Footnotes:
[F1] These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
--- Holdings ---
[Holding #1]
Security: Common Stock, $0.01 par value
Ownership: I (Indirect)
Footnotes:
[F2] The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
[Holding #2]
Security: Common Stock, $0.01 par value
Ownership: I (Indirect)
Footnotes:
[F3] Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.
[Holding #3]
Security: Common Stock, $0.01 par value
Ownership: I (Indirect)
Footnotes:
[F3] Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.
--- Footnotes (Complete Index) ---
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2: The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F3: Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.
--- Signature ---
/s/ /s/ T.O. Odutayo, attorney-in-fact for Thomas C. Freyman (2026-05-12)